Form 4: GoodRx Director Kelly J. Kennedy Acquires Shares Through Vesting of Restricted Stock Units
SEC Form 4
GoodRx director Kelly J. Kennedy acquired 23,150 shares of Class A common stock through the vesting of restricted stock units.
Summary
- Kelly J. Kennedy, a director at GoodRx Holdings, Inc., acquired 23,150 shares of Class A common stock on December 21, 2024.
- This acquisition was a result of the vesting of restricted stock units (RSUs).
- The price per share for the acquisition was $4.44.
- Following the transaction, Kennedy directly owns 54,012 shares of Class A common stock.
- Additionally, 23,150 restricted stock units vested, with a total of 46,298 RSUs now owned.
Sentiment
Score: 7
Explanation: The transaction is a routine vesting of stock units, which is generally positive as it aligns director interests with shareholders. There is no indication of any negative sentiment.
Positives
- The vesting of restricted stock units indicates a positive alignment of interests between the director and the company's performance.
- The acquisition of shares by a director can be seen as a sign of confidence in the company's future prospects.
Industry Context
This is a standard transaction for a director of a public company, involving the vesting of previously granted equity compensation. It is common for directors to receive stock-based compensation as part of their overall remuneration package.
Comparison to Industry Standards
- The vesting of restricted stock units is a common practice for compensating directors and executives in publicly traded companies.
- The amount of shares acquired is typical for a director's equity compensation plan.
- Similar transactions are regularly reported by directors of other publicly listed companies.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 12/21/2024 | Date of the transaction where restricted stock units vested and shares were acquired. |
| 12/23/2024 | Date the SEC Form 4 was signed. |
Keywords
GoodRx, GDRX, Director, Kelly J. Kennedy, Stock Acquisition, Restricted Stock Units, Share Vesting, Class A Common Stock, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.